1-(2-Amino-4-hydroxy-3-methylphenyl)ethanone, 95%, 500mg

1-Benzyl-1H-pyrazole-5-carboxylic acid, >95%, 250mg

2,2'-(Ethane-1,2-diylbis(oxy))diethanamine, 95.0%, 100g

1-(tert-Butoxycarbonyl)-3-methylazetidine-3-carboxylic acid, 95.0%, 10g

D(+)-Trehalose dihydrate, 25 g

(S)-methyl 5-((S)-1,1-dimethylethylsulfinamido)-5-(4-morpholinophenyl)-3-oxo-5-(thiophen-3-yl)pentanoate, 97%, 100mg

3-(4-tert-butylphenyl)prop-2-ynoic acid, 95.0%, 2g

4-(Methylthio)thiobenzamide, 250mg

5-Bromo-2-chloropyrimidine>97.0%(GC)25g

Phase contrast slide with phasing for PLPH 10x and S40x plan phase objectives

6-Bromo-1H-indazole-4-carbaldehyde, 98%, 25g

8-Nonenenitrile, 97.0%, 2g

(5-Bromo-2,4-dimethylphenyl)methanol, 98%, 500mg